A food allergy diagnosis is jarring at any age. But it is particularly unsettling when your baby or toddler is diagnosed. Parents worry that they may not be able to recognize the symptoms of a severe allergic reaction called anaphylaxis. Large-sized auto-injectors seems especially intimidating and parents often worry that the dose of epinephrine will overwhelm their infants’ small, little bodies.
Until recently, the 0.15mg dosed auto-injectors – typically used for children weighing between 33 and 66 lbs (15 – 30 kilograms) – were the only option for infants and toddlers. However, kaléo Pharma, the makers of Auvi-Q, just announced that the FDA has approved Auvi-q 0.1mg – a strength intended for infants and toddlers.
At a time when the rate of food allergies is still increasing and pediatricians are recommending the early introduction of peanuts and other allergens to prevent the development of food allergies, this device is arriving in the nick of time for food allergy parents. It is everyone’s hope that Auvi-q’s correctly-dosed auto-injector will embolden parents to confidently administer epinephrine to their young children without hesitation.
The FDA-approved Auvi-q 0.1mg will have several features that are better suited for little ones.
- It is dosed properly for infants and toddler weighing between 16.5 and 33 lbs (7.5 to 15 kilograms)
- It contains a needle length appropriate for smaller bodies, reducing incidents of injury.
If you’re not familiar with the Auvi-Q epinpehrine auto-injector, it’s a compact auto-injector about the size of a deck of cards. Auvi-Q features voice prompts to guide you through injection step-by-step and contains a needle that automatically retracts for safety.
If you have a baby or toddler and would like more information, here is a link to Auvi-q’s 0.1 page and, as always, speak with your doctor.